segment

AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis

...rketeddrug Remicade(r), total sales in this market segment have beengrowing substantially. About the Truelove-Witts and the Mayo scores The Truelove-Witts(TLW) score measures disease activity composed of 6 variables:number of stools per day; blood in stools; temperature; pulse;haemoglobin; and erythrocyte s...

Avexa's Apricitabine Clinical Trial Update

...le blinded phase whichrepresents the first 24 week segment of its Phase IIb trial.Patients have now progressed into the open-label section of thetrial (weeks 24 to 48) and will continue to receive 800mgapricitabine twice a day as part of their daily treatment regime.The Company expects to release results fro...

Bio-Matrix Scientific's Dr. O'Neill Sees University of Pittsburgh's Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells

...ty plans to cater to the growing stem cellresearch segment of the $75 billion biotechnology and medicaldevice industry. DISCLAIMER: This news release may contain forward-lookingstatements. Forward-looking statements are inherently subject torisks and uncertainties, some of which cannot be predicted orquanti...

Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -

...ral health medicalscience company. Its Cold Remedy segment is a leading marketer andmanufacturer of the COLD-EEZE(R) family of lozenges, gums and sugarfree tablets clinically proven to cut the common cold nearly inhalf. COLD-EEZE customers include leading national wholesalers anddistributors, as well as inde...

Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference

...opportunities." Patients randomized in the second segment (cohorts 4 to 6) ofthis Phase I/II study are curre...bset ofsubjects. Data from cohorts in the Phase II segment are anticipatedto provide additional insight into clinical observations andduration of response, as ...

Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema

...ment options forHAE patients." The prophylactic segment of the CHANGE study was aplacebo-controlled, double-blind, multi-center, crossover trialdesigned to determine the efficacy of C1-INH in preventing theonset of HAE attacks. In the study, 24 patients were randomlyassigned to one of two treatment groups...

Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD

...he heart-health and heart-diseasesmarkets, and the segment of the population that is physicallyactive. www.mitopharm.com At HKUST, scientific studies have identified biochemical actionsof MitoPharm's key Compound, demonstrating that it enhances themitochondrial glutathione antioxidant status, a crucial fact...

Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents

... non-randomized study of 60 patients with ST segment elevation AMI with one infarct lesion in a single vessel. The primary endpoint is stent thrombosis at 30 days post-procedure. Patient follow-up is underway, and results will be announced in October at TCT 2007 in Washington, D.C. ...

Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer

...rson to the next. Thers6983267 SNP is located in a segment of DNA that has few known orpredicted genes for prostate cancer. The researchers also confirm that a previous finding of adifferent variant, marked by SNP rs1447295, is also associated withprostate cancer. The rs1447295 SNP is located nearby on the ...

Presentations at American College of Cardiology Meeting Highlight New Opportunities for HDL Therapy

...analysis of data collected by IVUS.Measurements of segment plaque volume, percentage atheroma volume,plaque thickness, discrete lesion analysis, and other IVUSvariables will be analyzed and employed to select effectivenessendpoints for a future study. The IVUS analysis will be conductedat two core IVUS labor...

First Study To Show Positive Benefit On Atherosclerosis For People With Early Signs Of Diseased Arteries

... in totalatheroma volume in the most diseased 10mm segment of the targetvessel (p CRESTOR brought about a 6.8 per cent (median) reduction in totalatheroma volume in the entire target vessel (p<0.001) –secondary endpoint These changes were associated with a 53 per cent reduction in LDL-C(p ORION (Ou...